Why the study?
Does congestive heart failure or poor renal function alter the elimination of quinidine?
Does congestive heart failure or poor renal function alter the elimination of quinidine?
Quinidine elimination appears to be grossly normal in patients with congestive heart failure or poor renal function, indicating that major dose adjustments may not be necessary for these conditions.
Answers are grounded in this paper and cite their sources.
Quinidine half-life similar in heart failure or renal impairment; leaves open whether dosing adjustments are needed.
Plasma quinidine half-life values, determined by a relatively specific double extraction method in eight patients with poor renal function, eight with congestive heart failure, and nine controls were similar for all groups. When quinidine was measured by a nonspecific fluorescent method, the half-life values calculated for the uremic patients were longer than those for the controls. The nonspecific method does not differentiate slow biotransformation of quinidine from normal biotransformation but slow excretion of metabolites. Steady-state plasma quinidine concentrations were measured in 14 patients treated for arrhythmias and 12 with congestive heart failure. Therapeutic effectiveness was associated with concentrations of 2.3 to 5.0 μg per milliliter and ineffectiveness with lower levels or complicating illnesses. The relation of dose to steady-state blood level was similar for the two groups. Quinidine elimination appears to be grossly normal in patients with congestive heart failure or poor re...
No takes yet. Share an insight, caveat, or question.
Kessler et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: